Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older who have been diagnosed with a pancreatic neuroendocrine neoplasm (a type of tumour in the pancreas), confirmed by a tissue sample taken from any location in the body, such as the original tumour site or a spread (metastatic) site.
- Both newly diagnosed and previously diagnosed cases are eligible, regardless of the grade or stage of the condition.
- People who are willing and able to follow the study procedures throughout the trial.
Who may not be able to join:
- People who are unable to give informed consent to participate in the study.
- For people who have not previously had a broad genetic (germline) test covering at least 80 genes, the following additional restrictions apply:
- People who cannot speak or read one of the languages supported by the genetic testing station — currently English, Korean, Japanese, Vietnamese, Russian, Tagalog, Farsi, Spanish, Cantonese, Mandarin, or Arabic (confirm with trial site if your language is not listed).
- People who currently have an active blood cancer (such as leukaemia or lymphoma).
- People who have previously had a bone marrow or stem cell transplant from another person.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Emily Bergsland, MD, University of California, San Francisco
Phone: (415) 502-6313
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of overall pathogenic germline mutations
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.